Mahamaya Lifesciences Limited (BSE: 544611)
Materials · Chemicals · IN
Rs186.00
+2.62% today · +60.3% 1Y
Mahamaya Lifesciences Limited (BSE: 544611) operates in the Chemicals industry within the Materials sector. The company is valued at $45.53M.
Over the last twelve months the share price has gained 60.3%, trading between 111.00 and 205.05.
Tweenvest scores Mahamaya Lifesciences Limited across four factors: quality 45/100. Its strongest factor is quality.
544611 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.53M
- Revenue (TTM)
- $35.07M
- P/E
- 22.33
- EPS
- 8.33
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs205.05
- 52-week low
- Rs111.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.41M
- Employees
- —
- Next earnings
- —
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.59B | $487.20 | -0.58% |
| L'Air Liquide S.A.ENXTPA: AI | $124.62B | €167.78 | +0.05% |
| The Sherwin-Williams CompanyNYSE: SHW | $84.57B | $350.45 | +1.07% |
| Ecolab Inc.NYSE: ECL | $81.17B | $289.54 | +0.89% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.11B | ¥6,005.00 | -0.76% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.66B | $303.85 | -0.78% |
| Corteva, Inc.NYSE: CTVA | $55.25B | $83.05 | +0.29% |
| BASF SEXTRA: BAS | $51.92B | €51.68 | -1.43% |
Figures last refreshed Aug 18, 2026.